novo nordisk semaglutide pill Nordisk's Ozempic Sister Drug Rybelsus Cuts Heart Risk in Large Study Novo Nordisk's weight-loss pill wins

Semaglutide is not a treatment for type 1 diabetes or diabetic ketoacidosis

Wilding JP, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MT, Wadden TA, Wharton S

Results depend on your dose, adherence, diet quality, exercise, and genetic factors that PlexusDx's Precision Peptide test can reveal

Researchers at Mass Eye and Ear in Boston, Massachusetts, a Harvard Medical School teaching hospital, became motivated late last summer to look at whether todays highly sought-after weight-loss drugs might be associated with an increased risk of NAION, after three patients, all taking semaglutide, were diagnosed with the condition within the same week